Abstract | OBJECTIVE: STUDY DESIGN: We retrospectively reviewed the clinical follow-up of all women who were diagnosed with partial hydatidiform mole at our institution from 1983 to 2003. RESULTS: One hundred sixty-three patients were identified with a median age of 23 years (range, 14-42 years). Seventy-four patients (45%) attained undetectable levels of human chorionic gonadotropin; none of the patients had gestational trophoblastic neoplasia. Forty patients completed the 6 months of recommended follow-up; 6 patients conceived during surveillance, and 28 patients did not return for any further office visits 1 to 5 months after achieving remission. Eighty-three patients (51%) were lost to follow-up before normalization of human chorionic gonadotropin. Six women (4%) had stage I gestational trophoblastic neoplasia during surveillance. CONCLUSION:
|
Authors | Isaac Lavie, Gautam G Rao, Diego H Castrillon, David S Miller, John O Schorge |
Journal | American journal of obstetrics and gynecology
(Am J Obstet Gynecol)
Vol. 192
Issue 5
Pg. 1362-4
(May 2005)
ISSN: 0002-9378 [Print] United States |
PMID | 15902109
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Chorionic Gonadotropin
(blood)
- Female
- Gestational Trophoblastic Disease
(blood, diagnosis, epidemiology, pathology)
- Humans
- Hydatidiform Mole
(blood, surgery)
- Incidence
- Neoplasm Staging
- Population Surveillance
- Postoperative Period
- Pregnancy
- Retrospective Studies
- Time Factors
|